Admission Date:  [**2115-7-20**]              Discharge Date:   [**2115-8-1**]  Date of Birth:  [**2048-7-14**]             Sex:   M  Service: MED  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 6114**] Chief Complaint: Hematemesis  Major Surgical or Invasive Procedure: Esophagogastroduodenoscopy and esophageal biopsy Blood transfusions Esophageal Ultrasound  History of Present Illness: Pt is a 66 yo M with a h/o CAD (s/p CABG x 3 [**10-30**] and ICD placement [**2-28**]), MVR, A.fib, HTN who presented to the ED w/ hematemesis.
On [**7-15**] his [**Month/Year (2) 263**] was found to be subtherapeutic 1.4, so his coumadin was increased from 1mg to 2mg and started on Lovenox 40mg QD.
On [**7-19**] his [**Month/Year (2) 263**] was 4.7, both coumadin and lovenox were stopped.
K and started on heparin drip.
He is currently hemodynamically stable and on heparin drip for anti-coagulation.
Past Medical History: CABG x 3 ([**10-30**]) MVR s/p ICD placement ([**2-28**]) A.fib HTN Hypothyroidism   Social History: Denies ant T/A/D use.
Duodenum: Not examined Impressions: Stricture of the gastro-esophageal junction Barrett's esophagus Mass in the gastro-esophageal junction  ECHO [**2115-2-6**] Conclusions 1.
A bileaflet mitral valve prosthesis is present.
The distal LAD filled via left-to- left and right-to-left collaterals.
Also started on PPI IV.
Several services including surgery, oncology, radiation oncology were consulted.
Follow up appointments as an outpatient include Radiation oncology, thoracic oncology, and PET scan.
He needed to be on anticoagulation but because of the bleeding his [**Date Range 263**] was reversed.
After the EGD he was started on heparin and the PTT was maintained between 60-80 as per cardiology recommendations.
After the EUS he was able to be transitioned to coumadin in anticipation of discharge.
The beta blocker was added once his BP returned to the 120's/80's and slowly increased to his normal dose of metoprolol 25 mg [**Hospital1 **].
CAD- Aspirin was held secondary to the bleeding.
Beta blocker as above.
It was advised that he follow up with pulmonology during his cancer therapy and have regular PFT's.
Hypothyroidism- Continued his levothyroxine dose from home.
9.PPx: Patient was on PPI and heparin until his coumadin was therapeutic (morning of discharge)  Medications on Admission: Levothyroxine 100mcg QD, Atenolol 25 mg QD, Lisinopril 20mg QD, HCTZ 25mg QD, Zocor5mg QD, Coumadin 1mg QD   Discharge Medications: 1.
Simvastatin 10 mg Tablet Sig: One (1) Tablet PO QD (once a day).
Levothyroxine Sodium 100 mcg Tablet Sig: One (1) Tablet PO QD (once a day).
Pantoprazole Sodium 40 mg Tablet, Delayed Release (E.C.)
Warfarin Sodium 1 mg Tablet Sig: as directed Tablet PO HS (at bedtime): No coumadin tonight, repeat [**Hospital1 263**] [**2115-8-2**], further medication adjustments [**First Name8 (NamePattern2) **] [**First Name8 (NamePattern2) 2270**] [**Last Name (NamePattern1) 32624**] ([**Telephone/Fax (1) 54042**].
Atenolol 25 mg Tablet Sig: One (1) Tablet PO once a day.
Discharge Disposition: Home  Discharge Diagnosis: Esophageal adenocarcinoma Upper gastrointestinal bleeding Anemia,acute blood loss Elevated creatinine Anticoagulation for mitral valve replacement Barrett's esophagus Coronary Artery Disease   Discharge Condition: Stable, hematocrit stabilized, [**Last Name (STitle) 263**] 4.1 with followup [**Hospital 191**] [**Hospital3 **].
Discharge Instructions: 1)Have your [**Hospital3 263**] checked on [**2115-8-2**] and results to be communicated to [**Company 191**] Anticoagulation service, your coumadin will be adjusted based on these results by [**First Name8 (NamePattern2) 2270**] [**Last Name (NamePattern1) 32624**] ([**Telephone/Fax (1) 54042**].
2) You will need a repeat chemistry next week to check for resolution of your creatinine, results to be followed by your primary care physician.
